- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07712133
Improving Radon Education and Awareness in Cancer Patients and Their Extended Community
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kathryn Weaver
- Phone Number: 801-646-4458
- Email: kathryn.weaver@hci.utah.edu
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- Huntsman Cancer Institute/ University of Utah
-
Contact:
- Kathryn Weaver
- Phone Number: 801-646-4458
- Email: kathryn.weaver@hci.utah.edu
-
Principal Investigator:
- Judy Ou, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult age 18 or older
- Patient of HCI or friend/family or caregiver of patient of HCI (eligible if living in same home or different homes)
- Resident of Utah, Wyoming, Idaho, Montana, or Nevada
- Able to provide consent
Exclusion Criteria:
- Below age 18
- Resident of a state other than Utah, Wyoming, Idaho, Montana, or Nevada
- Not able to provide consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Radon Educational Session
One short, educational intervention presentation will be given.
The educational component is estimated to take 15-30 minutes, depending on how many questions people have.
|
A study staff member will deliver a short educational intervention about radon via PowerPoint with a standardized script to participants. The intervention can be delivered online or in person. If in person, the caregiver and patient will listen to the presentation given by the study team member. If done online, the presentation will be conducted by a study team member using secured video conference software (e.g. Zoom, Teams). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Radon Knowledge
Time Frame: up to 1 day
|
To compare participants' pre- and post-intervention knowledge about radon based on demographics and estimated residential radon levels.
Radon knowledge will be assessed using a questionnaire with total scores ranging from 0 to 5, where higher scores indicate greater radon knowledge and lower scores indicate less radon knowledge.
|
up to 1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Participants that Test for Radon
Time Frame: up to 4 weeks
|
To identify the proportion of participants that test for radon after the intervention according to demographics, estimated residential radon levels, and offered financial incentive.
|
up to 4 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Judy Ou, PhD, Huntsman Cancer Institute/ University of Utah
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 192718
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Survivorship
-
Dana-Farber Cancer InstitutePatient-Centered Outcomes Research InstituteRecruitingCancer SurvivorshipUnited States
-
Arash Asher, MDCompletedCancer | SurvivorshipUnited States
-
University of RochesterCompletedCancer SurvivorshipUnited States
-
University of OklahomaOklahoma State UniversityRecruiting
-
The University of Texas Health Science Center,...National Cancer Institute (NCI)Enrolling by invitationCancer SurvivorshipUnited States
-
The University of Hong KongUniversity of VictoriaCompletedCancer | SurvivorshipHong Kong
-
University of OttawaCompleted
-
Memorial Sloan Kettering Cancer CenterAmerican Cancer Society, Inc.; Herald Cancer Association; Brooklyn College Cancer...RecruitingCancer | SurvivorshipUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)Active, not recruitingCancer | SurvivorshipUnited States
-
Edge Hill UniversityFlinders UniversityNot yet recruitingNeoplasms | Cancer | Cancer SurvivorshipUnited Kingdom
Clinical Trials on Educational Presentation
-
Academisch Medisch Centrum - Universiteit van Amsterdam...National Institute for Public Health and the Environment (RIVM)CompletedColorectal Neoplasms | Serrated Polyp
-
University of ChicagoCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate CancerUnited States
-
Fu Jen Catholic UniversityCompletedSatisfaction, PersonalTaiwan
-
Hunter College of City University of New YorkActive, not recruitingMultiple SclerosisUnited States
-
Saglik Bilimleri UniversitesiRecruitingUrinary Catheterization, Nursing EducationTurkey (Türkiye)
-
Prim. Prof. Dr. Oliver Findl, MBARecruitingAge-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein OcclusionAustria
-
Shandong UniversityCompletedArtificial Intelligence | Optical Enhancement Endoscopy | Magnifying EndoscopyChina
-
Prim. Prof. Dr. Oliver Findl, MBAUnknown